Is Dimerix Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Dimerix Ltd (DXB.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Dimerix Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Dimerix Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Dimerix Ltd?

Muslim investors may consider investing in Dimerix Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Dimerix Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of Dimerix Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Dimerix Ltd updated?

The Shariah compliance status of Dimerix Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Dimerix Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Dimerix Ltd?

You can check the latest Shariah compliance status of Dimerix Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

DXB.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: October 19, 2025

Report Source: 2025 Annual Report

Analyst's Ratings for Dimerix Ltd (DXB.AX)

Based on 5 analysts giving stock ratings to Dimerix Ltd in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Dimerix Ltd. Stock Analysis DXB.AX

Australia Health Care Micro Cap Report: 2025 Annual

Dimerix Ltd. engages in the investment of the research and development of biopharmaceutical drugs. The company is headquartered in Melbourne, Victoria. The firm is focused on developing lives of patients with inflammatory diseases, including both kidney and respiratory diseases. The company develops and commercializes patient preferred pharmaceutical products for global markets using its receptor technology to identify and develop drugs in areas with an unmet need. The firm is focused on developing its Phase III product candidate DMX-200 (QYTOVRA), for Focal Segmental Glomerulosclerosis (FSGS) kidney disease and is also developing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD). Its Receptor Heteromer Investigation Technology (Receptor-HIT) is a scalable and globally applicable technology platform enabling the understanding of receptor interactions to rapidly screen and identify new drug opportunities. Its products target multiple global territories, with the initial focus predominantly on the United States and European markets.

Key Statistics of Dimerix Ltd (DXB.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.22AUD0.23

Today's Open

AUD0.22

Volume

1.89M

P/E Ratio (TTM)

52 Week Range

AUD0.20AUD0.67

Market Cap

138.09M

Avg. Volume

546.98K

Dividend Yield

Financial Metrics & Statements of Dimerix Ltd (DXB.AX)

FAQ's for Dimerix Ltd (DXB.AX)

According to Musaffa’s Shariah screening methodology, Dimerix Ltd (DXB.AX) is currently classified as NOT HALAL as of October 2025. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.